{
  "success": true,
  "pagesUsed": [
    1,
    2,
    7
  ],
  "modelUsed": "gemini-2.5-pro",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "Study Objectives",
        "text": "Study Objectives",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "Study Objectives",
        "sectionType": {
          "id": "9433343d-8acf-4f69-8447-dc9e7e40caa9",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_1_1"
        ]
      },
      {
        "id": "nc_2",
        "name": "Treatment",
        "text": "Treatment",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "5",
        "sectionTitle": "Treatment",
        "sectionType": {
          "id": "1c290d6b-587d-4306-bd7e-9dda5605ed7c",
          "code": "Treatment",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_2_1",
          "nci_2_2",
          "nci_2_3"
        ]
      },
      {
        "id": "nc_3",
        "name": "Assessments",
        "text": "Assessments",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "6",
        "sectionTitle": "Assessments",
        "sectionType": {
          "id": "fbcdb48f-8e5f-41db-9c1e-d3de24695a71",
          "code": "Assessments",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Assessments",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_3_1",
          "nci_3_2"
        ]
      },
      {
        "id": "nc_4",
        "name": "Study Procedures",
        "text": "Study Procedures",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "7",
        "sectionTitle": "Study Procedures",
        "sectionType": {
          "id": "1bd71685-5c0b-4cae-b9f5-936cb8ff0970",
          "code": "Study Procedures",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Procedures",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2",
          "nci_4_3"
        ]
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_1_1",
        "name": "Study Endpoints",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2",
        "sectionTitle": "Study Endpoints"
      },
      {
        "id": "nci_2_1",
        "name": "Tumor Assessment Requirements",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.2",
        "sectionTitle": "Tumor Assessment Requirements"
      },
      {
        "id": "nci_2_2",
        "name": "Treatment Schedule",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.3.3.1",
        "sectionTitle": "Treatment Schedule"
      },
      {
        "id": "nci_2_3",
        "name": "Concomitant Medications",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.5.1",
        "sectionTitle": "Concomitant Medications"
      },
      {
        "id": "nci_3_1",
        "name": "Schedule of Activities",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.4",
        "sectionTitle": "Schedule of Activities"
      },
      {
        "id": "nci_3_2",
        "name": "Survival Follow-up",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.5.3",
        "sectionTitle": "Survival Follow-up"
      },
      {
        "id": "nci_4_1",
        "name": "Tumor Assessments",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.2.1",
        "sectionTitle": "Tumor Assessments"
      },
      {
        "id": "nci_4_2",
        "name": "Blinded Independent Central Review",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.2.3",
        "sectionTitle": "Blinded Independent Central Review"
      },
      {
        "id": "nci_4_3",
        "name": "Survival Follow-up",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.2.4",
        "sectionTitle": "Survival Follow-up"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "PRO",
        "expandedText": "Patient-Reported Outcome",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "PFS",
        "expandedText": "Progression Free Survival",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "CRF",
        "expandedText": "Case Report Form",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "HbA1c",
        "expandedText": "hemoglobin A1c",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "RECIST",
        "expandedText": "Response Evaluation Criteria in Solid Tumors",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "CYP3A",
        "expandedText": "Cytochrome P450 3A",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "CDK",
        "expandedText": "Cyclin-Dependent Kinase",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "DNA",
        "expandedText": "Deoxyribonucleic Acid",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "ER",
        "expandedText": "Estrogen Receptor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "AI",
        "expandedText": "aromatase inhibitor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "HR",
        "expandedText": "hormone receptor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_12",
        "abbreviatedText": "HER2",
        "expandedText": "Human Epidermal Growth Factor Receptor 2",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_13",
        "abbreviatedText": "HR",
        "expandedText": "Hazard Ratio",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_14",
        "abbreviatedText": "CI",
        "expandedText": "confidence interval",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 4,
      "itemCount": 9,
      "abbreviationCount": 14
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "PD-0332991 (Palbociclib) A5481023 (PALOMA-3)",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "3",
      "versionDate": "2015-10-20",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "PRO",
          "expansion": "Patient-Reported Outcome"
        },
        {
          "abbreviation": "PFS",
          "expansion": "Progression Free Survival"
        },
        {
          "abbreviation": "CRF",
          "expansion": "Case Report Form"
        },
        {
          "abbreviation": "HbA1c",
          "expansion": "hemoglobin A1c"
        },
        {
          "abbreviation": "RECIST",
          "expansion": "Response Evaluation Criteria in Solid Tumors"
        },
        {
          "abbreviation": "CYP3A",
          "expansion": "Cytochrome P450 3A"
        },
        {
          "abbreviation": "CDK",
          "expansion": "Cyclin-Dependent Kinase"
        },
        {
          "abbreviation": "DNA",
          "expansion": "Deoxyribonucleic Acid"
        },
        {
          "abbreviation": "ER",
          "expansion": "Estrogen Receptor"
        },
        {
          "abbreviation": "AI",
          "expansion": "aromatase inhibitor"
        },
        {
          "abbreviation": "HR",
          "expansion": "hormone receptor"
        },
        {
          "abbreviation": "HER2",
          "expansion": "Human Epidermal Growth Factor Receptor 2"
        },
        {
          "abbreviation": "HR",
          "expansion": "Hazard Ratio"
        },
        {
          "abbreviation": "CI",
          "expansion": "confidence interval"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "PD-0332991 (Palbociclib) A5481023 (PALOMA-3)",
        "version": "3",
        "versionDate": "2015-10-20"
      },
      "sections": [
        {
          "number": "2",
          "title": "Study Objectives",
          "type": "Objectives",
          "subsections": [
            {
              "number": "2.2",
              "title": "Study Endpoints"
            }
          ]
        },
        {
          "number": "5",
          "title": "Treatment",
          "type": "Treatment",
          "subsections": [
            {
              "number": "5.2",
              "title": "Tumor Assessment Requirements"
            },
            {
              "number": "5.3.3.1",
              "title": "Treatment Schedule"
            },
            {
              "number": "5.5.1",
              "title": "Concomitant Medications"
            }
          ]
        },
        {
          "number": "6",
          "title": "Assessments",
          "type": "Assessments",
          "subsections": [
            {
              "number": "6.4",
              "title": "Schedule of Activities"
            },
            {
              "number": "6.5.3",
              "title": "Survival Follow-up"
            }
          ]
        },
        {
          "number": "7",
          "title": "Study Procedures",
          "type": "Study Procedures",
          "subsections": [
            {
              "number": "7.2.1",
              "title": "Tumor Assessments"
            },
            {
              "number": "7.2.3",
              "title": "Blinded Independent Central Review"
            },
            {
              "number": "7.2.4",
              "title": "Survival Follow-up"
            }
          ]
        }
      ]
    }
  }
}